You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Alcohol, tobacco, illegal drugs and psychoactive medication (mis)use are associated with a higher likelihood of developing several diseases, (traffic) injuries and crimes. These substances reduce quality of life and increase the health care and law enforcement costs, productivity losses, etc. Consequently, the social and economic impact of substances on society is substantial. The SOCOST study estimates for the first time social costs for alcohol, tobacco, illegal drugs and psychoactive medication in Belgium for the year 2012. This cost-of-illness study presents the direct costs, the indirect cost as well as the intangible costs related to substance (mis)use. This research was commissioned by the Belgian Federal Science Policy Office (BELSPO) in the framework of the Federal Research Programme Drugs. Two universities cooperated: Ghent University, Institute for International Research on Criminal Policy (IRCP) and the Vrije Universiteit Brussel, Interuniversity Centre for Health Economics Research (I-CHER). The research was conducted under supervision of prof. dr. Freya Vander Laenen, prof. dr. Koen Putman, prof. dr. Lieven Pauwels, prof. dr. Wim Hardyns and prof. dr. Lieven Annemans.
"Drawing partly from an online support group for dementia caregivers, this book demonstrates that this country faces an elder care crisis. Our elder care system rests on the exploitation of workers, mostly women and people of color, who are paid too little to make ends meet and imposes unsustainable burdens on family members"--
Any effort to gather evidence may prove pointless without ensuring its admissibility. Nevertheless, the EU, while developing instruments for smooth gathering of evidence in criminal matters, is not taking much effort to enhance its admissibility. Due to the lack of common rules in this matter, gathering and use of evidence in the EU cross-border context is still governed by the domestic law of the member states concerned. This may lead to situations where, given the differences between legal systems across the EU, evidence collected in one member state will not be admissible in other member states. Due to the fact that the Lisbon Treaty opened the possibility to adopt minimum rules concernin...
October 16-18, 2017 Rome, Italy Key Topics : Managing Dementia, Diagnosis and Symptoms, Imaging Techniques, Pathophysiology and Disease Mechanisms, Geriatrics and Cognitive Disorder, Amyloid Protein in Dementia, Care Practice and Awareness, Therapeutic Targets, Animal Models and Translational Medicine, Vascular Dementia, Alzheimers disease and Dementia, Traumatic brain injury, Dementia with Lewy Bodies, Alzheimers clinical trials and studies,